Colm McAlinden is one of the few who has trained as an optometrist, academic and ophthalmic surgeon. He originally graduated from Cardiff University with a first class honours in Optometry, followed by a period at Moorfields Eye Hospital in London. This was followed by a Masters and a PhD in Refractive Surgery. He then undertook a post-doctoral research fellowship at Flinders University in Australia. Subsequently he joined Swansea University, Graduate Entry Medical School, graduating in Medicine and Surgery (MB BCh) with elective periods at the Massachusetts Eye and Ear Infirmary, Harvard University with the Boston keratoprosthesis group and the Cornea Department at the Hôpital de la Timone in Marseille, France. He undertook his medicine and surgery posts in Wales and Bristol, during which time he was awarded an MD for his research achievements. Following this, Colm entered Ophthalmology specialist training in Wales and has been awarded Fellowship status with both the Royal College of Ophthalmologists (FRCOphth) and the European Board of Ophthalmology (FEBO). More recently, he was also awarded the sub-specialist certificate in laser and refractive surgery (CertLRS) from the Royal College of Ophthalmologists. He has also completed a PGCert in Medical Education at the University of Cambridge.
Colm is currently working at the renowned Corneo Plastic Unit & Eye Bank, Queen Victoria Hospital, East Grinstead and is a Visiting Professor at Wenzhou Medical University as well as the Eye & ENT Hospital of Fudan University, Shanghai. He supervises PhD students and sits on the editorial board for 7 peer reviewed journals. He has broad research interests including patient reported outcome psychometrics, cornea, cataract and refractive surgery, evaluation of ophthalmic instrumentation, public health and epidemiology. He developed the Quality of Vision (QoV) questionnaire which has become a highly utilised tool to evaluate outcomes in cataract and refractive surgery across clinical practice, research studies, clinical trials and FDA and CE regulatory approval studies. He is a prolific researcher; a H-index of 56 with over 170 publications in peer reviewed journals, book chapters and conference presentations with numerous awards to his name